ĀÜĄņĀŅĀ×

Steven Hartman spent over 25 years as a private equity investor. When his neighbor, Michelle, approached him with the various problems with epinephrine auto-injectors and how the allergy community was at risk, he immediately recognized that there was an opportunity to find A Better Way to deliver the epinephrine medication. Stevenā€™s background and experience executing complex business transactions was the perfect complement to Michelleā€™s vision and since then they have worked tirelessly to bring Bryn Pharma from an idea to a reality.

Prior to founding Bryn Pharma, Mr. Hartman was a Partner, Co-Chief Operating Ofļ¬cer, Chief Compliance Ofļ¬cer and General Counsel of a large middle market private equity ļ¬rm. Mr. Hartman had various roles including participating as a voting member on all investment committees, responsible for all legal aspects of the private equity ļ¬rm and its portfolio companies, responsible for all ļ¬rm and portfolio company corporate governance. Mr. Hartman headed a team of investment professionals responsible for the negotiations of all investment activities from initial investment through investment realization and was responsible for creating complex legal, ļ¬nancial and tax structuring for all of investment activities. Steven was responsible for all domestic and foreign compliance matters for the ļ¬rm and its afļ¬liates.

Steven earned a BS from UC Berkeley and JD/MBA from UCLA.